Market Overview:
The global antacids market reached a value of US$ 6.35 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 8.27 Billion by 2027 exhibiting a CAGR of 4.20% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use industries. These insights are included in the report as a major market contributor.
Antacids are over-the-counter (OTC) medications that neutralize the acid in the stomach to relieve indigestion and heartburn. They contain ingredients such as sodium bicarbonate, aluminum, magnesium hydroxide, and calcium and are commonly available in convenient chewable tablets, powder, and liquid forms. Antacids are widely used for treating sore stomach, dyspepsia discomfort, stomach ulcers, inflammation, acid indigestion, and stomach upset. Acid neutralizers, promotility agents, and proton pump inhibitors are common drugs that weaken the acid in the stomach. They assist in protecting the stomach lining from the duodenum, esophagus, and harsh acids released while eating. They are self-prescribed medications and act by neutralizing the acid in the stomach and inhibiting pepsin.
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
Antacids Market Trends:
The increasing prevalence of gastroesophageal reflux diseases (GERD) is one of the key factors driving the growth of the market. Antacids are widely used as they are cost-effective and assist in relieving inflammation, swelling, pain, and irritation associated with heartburn. In line with this, changing lifestyles, such as irregular dietary habits, sleep patterns, and sedentary lifestyles, is positively impacting the market growth. Moreover, various product innovations, such as the development of raft-forming antacids that are safe and strong medications that provide higher efficacy and increased duration of action, are providing an impetus to the market growth. Additionally, the widespread adoption of chewable tables in different flavors that are easy to store, provide the correct amount of dosage, and improve patient adherence is favoring the market growth. Other factors, such as the rising geriatric population that are prone to acidic complications, easy product availability through e-commerce platforms, and the increasing prevalence of heartburn among the masses, are creating a positive outlook for the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global antacids market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on drug class, formulation type and distribution channel.
Breakup by Drug Class:
www.imarcgroup.com
Note: Values and trends in the above chart consists of dummy data and are only shown here for representation purpose. Kindly contact us for the actual market size and trends.
- Proton Pump Inhibitors
- H2 Antagonist
- Acid Neutralizers
- Pro-Motility Agents
Breakup by Formulation Type:
- Tablet
- Liquid
- Powder
- Others
Breakup by Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Others
Breakup by Region:
To get more information on the regional analysis of this market, Request Sample
- North America
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited.
Report Coverage:
| Report Features |
Details |
|---|
| Base Year of the Analysis |
2021 |
| Historical Period |
2016-2021 |
| Forecast Period |
2022-2027 |
| Units |
US$ Billion |
| Segment Coverage |
Drug Class, Formulation Type, Distribution Channel, Region |
| Region Covered |
Asia Pacific, Europe, North America, Latin America, Middle East and Africa |
| Countries Covered |
United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico |
| Companies Covered |
Abbott Laboratories, AstraZeneca plc, Bayer AG, Boehringer Ingelheim International GmbH, Dr. Reddy’s Laboratories Ltd., GlaxoSmithKline plc, Johnson & Johnson, Pfizer Inc., Procter & Gamble Company, Reckitt Benckiser Group PLC, Sanofi S.A., Sun Pharmaceutical Industries Ltd. and Takeda Pharmaceutical Company Limited. |
| Customization Scope |
10% Free Customization |
| Report Price and Purchase Option |
Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499 |
| Post-Sale Analyst Support |
10-12 Weeks |
| Delivery Format |
PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Questions Answered in This Report:
- How has the global antacids market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global antacids market?
- What are the key regional markets?
- What is the breakup of the market based on the drug class?
- What is the breakup of the market based on the formulation type?
- What is the breakup of the market based on the distribution channel?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global antacids market and who are the key players?
- What is the degree of competition in the industry?
1 Preface
2 Scope and Methodology
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 Executive Summary
4 Introduction
4.1 Overview
4.2 Key Industry Trends
5 Global Antacids Market
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 Market Breakup by Drug Class
6.1 Proton Pump Inhibitors
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 H2 Antagonist
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Acid Neutralizers
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Pro-Motility Agents
6.4.1 Market Trends
6.4.2 Market Forecast
7 Market Breakup by Formulation Type
7.1 Tablet
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Liquid
7.2.1 Market Trends
7.2.2 Market Forecast
7.3 Powder
7.3.1 Market Trends
7.3.2 Market Forecast
7.4 Others
7.4.1 Market Trends
7.4.2 Market Forecast
8 Market Breakup by Distribution Channel
8.1 Hospital Pharmacies
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Retail Pharmacies
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 Others
8.3.1 Market Trends
8.3.2 Market Forecast
9 Market Breakup by Region
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT Analysis
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 Value Chain Analysis
12 Porters Five Forces Analysis
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 Price Analysis
14 Competitive Landscape
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 Abbott Laboratories
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 AstraZeneca plc
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.2.3 Financials
14.3.2.4 SWOT Analysis
14.3.3 Bayer AG
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Boehringer Ingelheim International GmbH
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.5 Dr. Reddy’s Laboratories Ltd.
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.5.3 Financials
14.3.5.4 SWOT Analysis
14.3.6 GlaxoSmithKline plc
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Johnson & Johnson
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Procter & Gamble Company
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Reckitt Benckiser Group PLC
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
14.3.11 Sanofi S.A.
14.3.11.1 Company Overview
14.3.11.2 Product Portfolio
14.3.11.3 Financials
14.3.11.4 SWOT Analysis
14.3.12 Sun Pharmaceutical Industries Ltd.
14.3.12.1 Company Overview
14.3.12.2 Product Portfolio
14.3.12.3 Financials
14.3.12.4 SWOT Analysis
14.3.13 Takeda Pharmaceutical Company Limited
14.3.13.1 Company Overview
14.3.13.2 Product Portfolio
14.3.13.3 Financials
14.3.13.4 SWOT Analysis
List of Figures
Figure 1: Global: Antacids Market: Major Drivers and Challenges
Figure 2: Global: Antacids Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Antacids Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 4: Global: Antacids Market: Breakup by Drug Class (in %), 2021
Figure 5: Global: Antacids Market: Breakup by Formulation Type (in %), 2021
Figure 6: Global: Antacids Market: Breakup by Distribution Channel (in %), 2021
Figure 7: Global: Antacids Market: Breakup by Region (in %), 2021
Figure 8: Global: Antacids (Proton Pump Inhibitors) Market: Sales Value (in Million US$), 2016 & 2021
Figure 9: Global: Antacids (Proton Pump Inhibitors) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 10: Global: Antacids (H2 Antagonist) Market: Sales Value (in Million US$), 2016 & 2021
Figure 11: Global: Antacids (H2 Antagonist) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 12: Global: Antacids (Acid Neutralizers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 13: Global: Antacids (Acid Neutralizers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 14: Global: Antacids (Pro-Motility Agents) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Antacids (Pro-Motility Agents) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Antacids (Tablet) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Antacids (Tablet) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Antacids (Liquid) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Antacids (Liquid) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Antacids (Powder) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Antacids (Powder) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Antacids (Other Formulation Types) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Antacids (Other Formulation Types) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Antacids (Hospital Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Antacids (Hospital Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Antacids (Retail Pharmacies) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Antacids (Retail Pharmacies) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Antacids (Other Distribution Channels) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Antacids (Other Distribution Channels) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: North America: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: North America: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: United States: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: United States: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Canada: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Canada: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Asia-Pacific: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Asia-Pacific: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: China: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: China: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Japan: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Japan: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: India: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: India: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: South Korea: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: South Korea: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Australia: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Australia: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Indonesia: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 49: Indonesia: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 50: Others: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 51: Others: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 52: Europe: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 53: Europe: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 54: Germany: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 55: Germany: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 56: France: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 57: France: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 58: United Kingdom: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: United Kingdom: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: Italy: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: Italy: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Spain: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Spain: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Russia: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Russia: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Others: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Others: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 68: Latin America: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 69: Latin America: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 70: Brazil: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 71: Brazil: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 72: Mexico: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 73: Mexico: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 74: Others: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 75: Others: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 76: Middle East and Africa: Antacids Market: Sales Value (in Million US$), 2016 & 2021
Figure 77: Middle East and Africa: Antacids Market: Breakup by Country (in %), 2021
Figure 78: Middle East and Africa: Antacids Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 79: Global: Antacids Industry: SWOT Analysis
Figure 80: Global: Antacids Industry: Value Chain Analysis
Figure 81: Global: Antacids Industry: Porter's Five Forces Analysis
List of Tables
Table 1: Global: Antacids Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Antacids Market Forecast: Breakup by Drug Class (in Million US$), 2022-2027
Table 3: Global: Antacids Market Forecast: Breakup by Formulation Type (in Million US$), 2022-2027
Table 4: Global: Antacids Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 5: Global: Antacids Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 6: Global: Antacids Market: Competitive Structure
Table 7: Global: Antacids Market: Key Players